Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Richard A, Koup"'
Autor:
Julie E, Ledgerwood, Adam D, DeZure, Daphne A, Stanley, Emily E, Coates, Laura, Novik, Mary E, Enama, Nina M, Berkowitz, Zonghui, Hu, Gyan, Joshi, Aurélie, Ploquin, Sandra, Sitar, Ingelise J, Gordon, Sarah A, Plummer, LaSonji A, Holman, Cynthia S, Hendel, Galina, Yamshchikov, Francois, Roman, Alfredo, Nicosia, Stefano, Colloca, Riccardo, Cortese, Robert T, Bailer, Richard M, Schwartz, Mario, Roederer, John R, Mascola, Richard A, Koup, Nancy J, Sullivan, Barney S, Graham, Sarah, Romano
Publikováno v:
New England Journal of Medicine. 376:928-938
BackgroundThe unprecedented 2014 epidemic of Ebola virus disease (EVD) prompted an international response to accelerate the availability of a preventive vaccine. A replication-defective recombinant chimpanzee adenovirus type 3–vectored ebolavirus v
Autor:
Katie Ewer, Tommy Rampling, Navin Venkatraman, Georgina Bowyer, Danny Wright, Teresa Lambe, Egeruan B. Imoukhuede, Ruth Payne, Sarah Katharina Fehling, Thomas Strecker, Nadine Biedenkopf, Verena Krähling, Claire M. Tully, Nick J. Edwards., Emma M. Bentley, Dhanraj Samuel, Geneviève Labbé, Jing Jin, Malick Gibani., Alice Minhinnic, Morven Wilkie, Ian Poulton, Natalie Lella, Rachel Roberts, Felicity Hartnell, Carly Bliss, Kailan Sierra-Davidson, Jonathan Powlson, Eleanor Berrie, Richard Tedder, B. Chir., Francois Roman, Iris De Ryck, Alfredo Nicosia, Nancy J. Sullivan, Daphne A. Stanley, Olivier T. Mbaya, Julie E. Ledgerwood, Richard M. Schwartz, Loredana Siani, Stefano Colloca, Antonella Folgori, Stefania Di Marco, Riccardo Cortese, Edward Wright, Stephan Becker, Barney S. Graham, Richard A. Koup, Myron M. Levine, Ariane Volkmann, Paul Chaplin, Andrew J. Pollard, Simon J. Draper, D. Phil., W. Ripley Ballou, Alison Lawrie, Sarah C. Gilbert, and Adrian V. S. Hill
BACKGROUND\ud The West African outbreak of Ebola virus disease that peaked in 2014 has caused more than 11,000 deaths. The development of an effective Ebola vaccine is a priority for control of a future outbreak.\ud \ud METHODS\ud In this phase 1 stu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::180dc9091c76e4ca78fdb439784cfb18
https://westminsterresearch.westminster.ac.uk/download/73fc5235cecfad936d01e4885891d2bdbd8509ccc9118034132a348b6eac7ac2/444979/nejmoa1411627.pdf
https://westminsterresearch.westminster.ac.uk/download/73fc5235cecfad936d01e4885891d2bdbd8509ccc9118034132a348b6eac7ac2/444979/nejmoa1411627.pdf
Autor:
Douglas D. Richman, Michael Kilby, John W. Mellors, Marty Markowitz, Susan J. Little, Jeannette M. Whitcomb, Eric S. Daar, Richard A. Koup, Jean-Pierre Routy, Elizabeth Connick, Brian Conway, Lei Wang, Ann C. Collier, Nicholas S. Hellmann, Sarah Holte
Publikováno v:
New England Journal of Medicine. 347:385-394
Among persons in North America who are newly infected with the human immunodeficiency virus (HIV), the prevalence of transmitted resistance to antiretroviral drugs has been estimated at 1 to 11 percent.We performed a retrospective analysis of suscept